YSM News & Updates

Alzheimer’s and Parkinson’s disease drugs may be effective against pediatric leukemia; SARS-CoV-2 is on the decline in animals; exercise protects against cancer by routing fuel to muscles and away from tumors.

Study suggests autism is driven by a signaling imbalance in the brain; researchers identify molecules that spread Parkinson's pathology across brain cells; a gene mutation could be a target for preventing kidney scarring.

How researchers advocated for—and patients inspired—a potential new treatment for glioblastoma; a backup defense system in the gut could inform vaccine development; cortisol helps the brain build emotional memories.

Bridging preclinical research and clinical care for stroke treatment; a detailed image of cholera flagella could inform new treatments; microscopy technique provides nanoscale view of brain tissue.

A protective mechanism employed by the young brain could be a target for preventing neurodegeneration; Christopher Whitlow, MD, PhD, shares his vision as the new chair of the Department of Radiology and Biomedical Imaging; a new initiative brings hepatitis C treatment into the community.

How cancer cells compensate for missing chromosomes; two brain changes that could inform early detection of Parkinson's disease; a new imaging technique that can detect signs of aging and disease in cells.

An enzyme could be a target for treating degenerative joint diseases; more effective tuberculosis screening strategies could boost outcomes in high-risk populations; individuals with chronic hepatitis C infection have a higher risk of pancreatic cancer.

Researchers identify new routes for treating fibrosis; those at risk of losing Medicaid coverage have a higher burden of chronic disease; despite policy changes, patients with diabetes are still rationing insulin.

Individual differences in brain activity hold valuable information; ammonia in the gut drives appetite loss during recovery from acute illness; a dual-action vaccine holds promise for treating an aggressive skin cancer.

Researchers uncover a cellular mechanism that drives resistance to a targeted lung cancer drug; a dual approach may be more effective for treating some cancers; study highlights differences in diagnosis and outcomes for people with stomach cancer in the United States.